CompletedPhase 4NCT03405922
Perianal Nerval Block in Proctological Interventions
Studying Anal fistula
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital, Basel, Switzerland
- Principal Investigator
- Daniel SteinemannSt:Claraspital
- Intervention
- Placebo 40 mL Saline 0.9%(drug)
- Enrollment
- 166 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2018 – 2019
Study locations (1)
- St Claraspital, Basel, Switzerland
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03405922 on ClinicalTrials.govOther trials for Anal fistula
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07520500IFOC Compared With LIFT in High Anal FistulaCairo University
- RECRUITINGNCT07519850The Impact of Perianal Disease on Patient's Sex LifeAHEPA University Hospital
- RECRUITINGNCT07477496Recurrence and Anal Fistula Patient Reported Outcomes TrialNational and Kapodistrian University of Athens
- RECRUITINGNANCT07334678TROPIS Versus Coring Out Fistulectomy in High Anal FistulaCairo University
- RECRUITINGNANCT07399353Comparative Study: Fistula Rerouting vs. LIFT for High Perianal FistulaCairo University
- ENROLLING BY INVITATIONEARLY PHASE1NCT07128953Study on the Mechanism of Zuoqing San Promoting Postoperative Wound Healing of Anal Fistula by Inhibiting ROS-dependent NETosisThe Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine
- RECRUITINGNANCT07081373Study on Repeat Liposomal Bupivacaine for Post-Surgery Pain in Anal Fistula Patients.Sixth Affiliated Hospital, Sun Yat-sen University
- RECRUITINGNCT07021742BioHealx® Anal Fistula Device Post Market Surveillance StudySignum Surgical USA Inc.